FDA Webview
X
about-us-banner

Articles

Home /Articles / FDA Federal Register Notices

Guidance on Blood Donor Testing to Reduce Hepatitis B

11/29/2011

Guidance on Blood Donor Testing to Reduce Hepatitis B

11/28/2011

Federal Register Notice: FDA is making available a draft document, Guidance for Industry: Use of Nucleic Acid Tests (NAT) on Poole...

FDA Amends Emergency Authorization for Postal Service

11/28/2011

Federal Register Notice: FDA is amending the Emergency Use Authorization (EUA) for doxycycline hyclate tablet emergency kits for e...

Nominations Sought for Science Board

11/28/2011

Federal Register Notice: FDA requests nominations for voting members to serve on the Science Board to the FDA. Nominations receive...

FDA Withdraws NDA for Mylotarg

11/28/2011

Federal Register Notice: FDA is withdrawing approval of a Wyeth Pharmaceuticals’ NDA for Mylotarg (gemtuzumab ozogamicin) fo...

Science Board to Meet

11/28/2011

Federal Register Notice: FDA’s Science Board will meet 1/6/12 from 9 a.m. to 4 p.m. at the FDA White Oak Campus, 10903 New H...

OMB OKs Info on Biologic AERs

11/28/2011

FDA OKs Merial NADA for Bovine Parasites

11/28/2011

Federal Register Final rule: FDA is amending the animal drug regulations to reflect approval of an original NADA filed by Merial L...

Taxotere Not Withdrawn for S&E

11/28/2011

Federal Register Notice: FDA has determined that Taxotere (docetaxel) injection, 40 mg/mL was not withdrawn from sale for reasons...

Guidance on IVDs to Detect Human Papillomaviruses

11/28/2011

Federal Register Notice: FDA is making available a guidance, Establishing the Performance Characteristics of In Vitro Diagnostic D...